 |
Fentanyl Buccal
Tablet Relieves Stubborn Neuropathic Pain: Presented at AAN |
|
Pregabalin for
peripheral neuropathic pain: results of a multicenter,
non-comparative, open-label study in Indian patients |
|
Pregabalin: A
novel gamma-aminobutyric acid analogue in the treatment of
neuropathic pain, partial-onset seizures, and anxiety disorders |
|
EFNS guidelines on pharmacological treatment of neuropathic pain |
|
Researchers identify key protein involved in neuropathic pain |
|
Duloxetine: A balanced and selective norepinephrine- and
serotonin-reuptake inhibitor |
|
A single dose of gabapentin reduces acute pain and allodynia in
patients with herpes zoster |
|
Anticonvulsants for neuropathic pain syndromes: mechanisms of
action and place in therapy |
|
New Data Show Cymbalta Improved Physical, Social and Emotional
Functioning and Overall Health of Patients With Painful Diabetic
Neuropathy |
|
Treatment of postherpetic neuralgia |
|
Effectiveness of the lidocaine patch 5% on pain qualities in three
chronic pain states: assessment with the Neuropathic Pain Scale |
|
FDA Grants Priority Approval to Antidepressant Cymbalta
(Duloxetine) to Treat Diabetic Peripheral Neuropathic Pain |
|
EFNS: Lyrica (Pregabalin) Offers Sustained Relief Of Peripheral
Neuropathic Pain |
|
Neuromodulating drugs for the symptomatic treatment of neuropathic
pain |
|
Review of lidocaine patch 5% studies in the treatment of
postherpetic neuralgia |
|
How to Initiate and Monitor Infusional Lidocaine for Severe and/or
Neuropathic Pain (pdf) |
|
Management of herpes zoster (shingles) and postherpetic neuralgia |
|
Duloxetine May Be Effective for Treatment of Pain Associated With
Diabetic Neuropathy |
|
Evaluation and treatment of central pain syndromes |
|
Analgesic effect of dextromethorphan in neuropathic pain |
|
Current pharmacologic approaches to treating neuropathic pain |
|
Efficacy of lidocaine patch 5% in the treatment of focal
peripheral neuropathic pain syndromes: a randomized, double-blind,
placebo-controlled study |
|
Change in opioid use after the initiation of gabapentin therapy in
patients with postherpetic neuralgia |
|
Levetiracetam in the treatment of neuropathic pain: three case
studies
 |
Conclusion: In these 3 case studies, levetiracetam was
demonstrated to be an effective therapy in the treatment of
neuropathic pain. It has the benefits of a low incidence of
adverse events and an improvement in patients' sleep. |
|
|
DGReview of :"Levetiracetam in the treatment of neuropathic pain:
three case studies" |
|
Use of gabapentin for postherpetic neuralgia: Results of two
randomized, placebo-controlled studies |
|
Levetiracetam in the treatment of neuropathic pain: three case
studies |
|
The use of gabapentin for the
treatment of postherpetic neuralgia |
|
Neuropathic pain, essential medicines and adjuvant analgesics |
|
Guideline for the use of Neurontin® in the management of
neuropathic pain
|
|
Lamotrigine for HIV-associated painful sensory neuropathies: A
placebo-controlled trial
|
Conclusions: Lamotrigine was well-tolerated and effective for
HIV-associated neuropathic pain in patients receiving neurotoxic
antiretroviral therapy. Additional research is warranted to
understand the differing response among patients receiving
neurotoxic antiretroviral therapy compared with those not
receiving neurotoxic antiretroviral therapy. |
|
|
Postherpetic Neuralgia download
pdf version here |
|
Pfizer Receives FDA Approval To Market Neurontin (Gabapentin) For
Post-Herpetic Neuralgia |
|
Dextromethorphan Effective in Select Patients With Painful
Diabetic Neuropathy |
|
Gabapentin for neuropathic pain |
|
Lamictal
(Lamotrigine) Relieves Pain of Diabetic Neuropathy |
|
AAN: Lidoderm (Lidocaine Patch 5%) Effective for Neuropathic Pain |
|
Methadone in
the Treatment of Chronic Non-Malignant Pain-a 2-Year Review
|
We are
re-learning the benefits of methadone. Consider this medication in
the treatment of post-herpetic neuralgia. This
is a review of the article in Pain Medicine and a link to its
abstract. |
|
|
Intrathecal
Methylprednisolone for Intractable Postherpetic Neuralgia
|
This
is a review of the article in The New England Journal of
Medicine and a link to its
abstract. |
|
|
Stubborn
Neuropathic Pain Responds to Buproprion
|
Results showed that buproprion decreased weekly pain scores by
10-15 percent in each patient group for weeks two through six of
treatment (p<0.001). Dr. Semenchuck pointed out that while this
may seem relatively modest, "to a patient with chronic neuropathic
pain, this is a very meaningful difference". |
|
|
Long-term
ketamine subcutaneous continuous infusion in neuropathic cancer
pain |
